Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4H9P2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.615 |
CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.677 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.543 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.560 |
CLV_PCSK_PC7_1 | 32 | 38 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.396 |
DEG_APCC_DBOX_1 | 182 | 190 | PF00400 | 0.364 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.576 |
DOC_MAPK_gen_1 | 32 | 42 | PF00069 | 0.677 |
DOC_MAPK_gen_1 | 75 | 83 | PF00069 | 0.592 |
DOC_MAPK_MEF2A_6 | 35 | 44 | PF00069 | 0.731 |
DOC_MAPK_MEF2A_6 | 82 | 90 | PF00069 | 0.532 |
DOC_PP1_RVXF_1 | 73 | 80 | PF00149 | 0.668 |
DOC_PP2B_LxvP_1 | 65 | 68 | PF13499 | 0.674 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.578 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.391 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.413 |
LIG_14-3-3_CanoR_1 | 129 | 136 | PF00244 | 0.330 |
LIG_14-3-3_CanoR_1 | 248 | 254 | PF00244 | 0.726 |
LIG_14-3-3_CanoR_1 | 37 | 43 | PF00244 | 0.684 |
LIG_14-3-3_CanoR_1 | 55 | 62 | PF00244 | 0.648 |
LIG_14-3-3_CanoR_1 | 70 | 79 | PF00244 | 0.510 |
LIG_Actin_WH2_2 | 65 | 80 | PF00022 | 0.495 |
LIG_FHA_1 | 120 | 126 | PF00498 | 0.365 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.261 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.648 |
LIG_LIR_Gen_1 | 120 | 128 | PF02991 | 0.360 |
LIG_LIR_Gen_1 | 235 | 245 | PF02991 | 0.769 |
LIG_LIR_Gen_1 | 59 | 69 | PF02991 | 0.617 |
LIG_LIR_Gen_1 | 93 | 103 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 59 | 65 | PF02991 | 0.577 |
LIG_LIR_Nem_3 | 93 | 98 | PF02991 | 0.410 |
LIG_PDZ_Class_1 | 249 | 254 | PF00595 | 0.726 |
LIG_Pex14_2 | 91 | 95 | PF04695 | 0.350 |
LIG_SH2_CRK | 62 | 66 | PF00017 | 0.667 |
LIG_SH2_NCK_1 | 130 | 134 | PF00017 | 0.370 |
LIG_SH2_STAP1 | 121 | 125 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.370 |
LIG_SH2_STAP1 | 62 | 66 | PF00017 | 0.612 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.459 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.287 |
LIG_SH2_STAT5 | 191 | 194 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 2 | 5 | PF00017 | 0.739 |
LIG_SH3_1 | 179 | 185 | PF00018 | 0.474 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.446 |
LIG_SUMO_SIM_par_1 | 214 | 222 | PF11976 | 0.699 |
LIG_TRAF2_1 | 185 | 188 | PF00917 | 0.440 |
LIG_ULM_U2AF65_1 | 164 | 169 | PF00076 | 0.266 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.629 |
MOD_CK2_1 | 181 | 187 | PF00069 | 0.415 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.727 |
MOD_CK2_1 | 68 | 74 | PF00069 | 0.499 |
MOD_GlcNHglycan | 228 | 232 | PF01048 | 0.531 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.341 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.649 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.364 |
MOD_PIKK_1 | 246 | 252 | PF00454 | 0.758 |
MOD_PKA_2 | 128 | 134 | PF00069 | 0.326 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.670 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.614 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.302 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.351 |
MOD_Plk_4 | 201 | 207 | PF00069 | 0.234 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.385 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.413 |
MOD_SUMO_for_1 | 141 | 144 | PF00179 | 0.465 |
TRG_DiLeu_BaEn_2 | 232 | 238 | PF01217 | 0.589 |
TRG_DiLeu_BaEn_4 | 187 | 193 | PF01217 | 0.451 |
TRG_DiLeu_BaLyEn_6 | 18 | 23 | PF01217 | 0.699 |
TRG_ENDOCYTIC_2 | 121 | 124 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.345 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.575 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.576 |
TRG_ER_diArg_1 | 35 | 37 | PF00400 | 0.726 |
TRG_NES_CRM1_1 | 148 | 161 | PF08389 | 0.444 |
TRG_NES_CRM1_1 | 190 | 201 | PF08389 | 0.209 |
TRG_NLS_MonoExtC_3 | 164 | 170 | PF00514 | 0.270 |
TRG_NLS_MonoExtN_4 | 164 | 169 | PF00514 | 0.266 |
TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.405 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JNI9 | Bodo saltans | 32% | 71% |
A0A1X0P730 | Trypanosomatidae | 47% | 72% |
A0A3Q8IB53 | Leishmania donovani | 80% | 98% |
A4HY09 | Leishmania infantum | 80% | 98% |
D0A587 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 73% |
E9ARS3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 98% |
Q4QDQ0 | Leishmania major | 80% | 100% |
V5BEH9 | Trypanosoma cruzi | 46% | 90% |